Subscribe
Subscription banner for an ophthalmic newsletter

Breaking News

Alcon Recalls Systane Ultra PF Lot Over Potential Fungal Contamination
Alcon Recalls Systane Ultra PF Lot Over Potential Fungal Contamination Dec 30, 2024 Alcon Laboratories has announced a voluntary recall of Lot 10101 of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count.
FDA Clears SB-007 Gene Therapy IND for Stargardt Disease
FDA Clears SB-007 Gene Therapy IND for Stargardt Disease Dec 13, 2024 The FDA has cleared an Investigational New Drug (IND) application for SB-007, an adeno-associated viral (AAV) vector gene therapy targeting the root genetic cause of Stargardt disease, according to a press release from SpliceBio.
Bausch + Lomb Acquires ELIOS System, Expanding Glaucoma Treatment Options
Bausch + Lomb Acquires ELIOS System, Expanding Glaucoma Treatment Options Dec 12, 2024 Bausch + Lomb Corp. has announced the acquisition of Elios Vision Inc., the developer of the ELIOS procedure—a minimally invasive glaucoma surgery (MIGS) procedure utilizing an excimer laser.

 

a banner for OBN's Spotlight TV series. Showing 5 people in ophthalmic sector

Industry News

Cencora Completes Acquisition of Retina Consultants of America
Cencora Completes Acquisition of Retina Consultants of America Jan 06, 2025 Cencora has officially completed its acquisition of Retina Consultants of America (RCA), a management services organization (MSO) specializing in retina care, in a deal valued at $4.4 billion.
Ocugen Advances Phase 2 of OCU410 ArMaDa Clinical Trial
Ocugen Advances Phase 2 of OCU410 ArMaDa Clinical Trial Jan 06, 2025 Ocugen has announced that the second phase of the OCU410 ArMaDa clinical trial will continue following approval from the Data and Safety Monitoring Board (DSMB).
Regeneron Acquires UK-Based Biotech Oxular
Regeneron Acquires UK-Based Biotech Oxular Jan 06, 2025 Regeneron, a global biotechnology leader, has acquired Oxular, a UK-based clinical-stage company specializing in ocular delivery technology for retinal disorders.

Ophthalmic Research News

AI-Driven Discovery Uncovers Potential Treatment for Acute Glaucoma
AI-Driven Discovery Uncovers Potential Treatment for Acute Glaucoma Jan 03, 2025 Acute glaucoma, characterized by retinal ganglion cell (RGC) death due to acute ocular hypertension, is a sight-threatening condition.
Study Links Lower Socioeconomic Status to Increased Risk of Open Globe Injury and Poorer Outcomes
Study Links Lower Socioeconomic Status to Increased Risk of Open Globe Injury and Poorer Outcomes Jan 02, 2025 A research team has explored the connection between socioeconomic status (SES) and the incidence and outcomes of open globe injury (OGI).
Cyclodialysis Procedure with Scleral Reinforcement Effectively Lowers IOP in Open-Angle Glaucoma
Cyclodialysis Procedure with Scleral Reinforcement Effectively Lowers IOP in Open-Angle Glaucoma Dec 31, 2024 A recent study published in Clinical Ophthalmology demonstrated that a bio-interventional cyclodialysis procedure with allograft scleral reinforcement significantly lowered IOP in patients with open-angle glaucoma by enhancing uveoscleral outflow.

Ophthalmic Blog

2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies Dec 23, 2024 The year 2024 has been a remarkable period for advancements in ophthalmology, with groundbreaking innovations reshaping the landscape of eye disease treatment and diagnosis.
2024 Recap: Top 8 FDA Approvals in Ophthalmology
2024 Recap: Top 8 FDA Approvals in Ophthalmology Dec 16, 2024 The year 2024 has been a pivotal one for ophthalmology, with several novel FDA approvals introducing innovative treatments and technologies to the field
2024 Recap: Top 10 Breakthroughs in Ophthalmology Research
2024 Recap: Top 10 Breakthroughs in Ophthalmology Research Dec 09, 2024 2024 has been a landmark year for breakthroughs in ophthalmology research, showcasing transformative advancements that are shaping the future of eye care.
Ophthalmology Breaking News Subscribe